Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for human medicine

300241 (Harmonized System 2022 for 6-digit)

About

Overview This page contains the latest trade data of Human vaccines and similar products. In 2022, Human vaccines and similar products were the world's 30th most traded product, with a total trade of $87.8B.

Human vaccines and similar products are a part of Vaccines, blood, antisera, toxins and cultures.

Exports In 2022 the top exporters of Human vaccines and similar products  were Belgium ($33.5B), Ireland ($12.5B), United States ($8.11B), Germany ($7.55B), and France ($5.51B).

Imports In 2022 the top importers of Human vaccines and similar products were Belgium ($12B), United States ($9.88B), Germany ($8.7B), Japan ($8.19B), and Spain ($4.03B).

Ranking Human vaccines and similar products ranks 244th in the Product Complexity Index (PCI).

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Human vaccines and similar products. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)Belgium$33.5B
Top Destination (2022)Belgium$12B

In 2022 Human vaccines and similar products were the world's 30th most traded product (out of 5,606).

In 2022, the top exporters of Human vaccines and similar products were Belgium ($33.5B), Ireland ($12.5B), United States ($8.11B), Germany ($7.55B), and France ($5.51B).

In 2022, the top importers of Human vaccines and similar products were Belgium ($12B), United States ($9.88B), Germany ($8.7B), Japan ($8.19B), and Spain ($4.03B).

Explore Visualizations

Exporters of Human vaccines and similar products (2022)
[Click to Select a Country]

Importers of Human vaccines and similar products (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (false -  2022)Belgium$33.5B
Top Destination Growth (false -  2022)Belgium$12B

Between false and 2022, the exports of Human vaccines and similar products grew the fastest in Belgium ($33.5B), Ireland ($12.5B), United States ($8.11B), Germany ($7.55B), and France ($5.51B).

Between false and 2022, the fastest growing importers of Human vaccines and similar products were Belgium ($12B), United States ($9.88B), Germany ($8.7B), Japan ($8.19B), and Spain ($4.03B).

Explore Visualizations

Exporters of Human vaccines and similar products (NaN - 2022)

Importers of Human vaccines and similar products (NaN - 2022)

Net Trade

TOP NET EXPORTER (2022)Belgium$21.5B
TOP NET IMPORTER (2022)Japan$8.1B

This map shows which countries export or import more of Human vaccines and similar products. Each country is colored based on the difference in exports and imports of Human vaccines and similar products during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Human vaccines and similar products were Belgium ($21.5B), Ireland ($12B), France ($2.92B), Switzerland ($2.13B), and Spain ($1.17B).

In 2022, the countries that had a largest trade value in imports than in exports of Human vaccines and similar products were Japan ($8.1B), United Kingdom ($2.06B), Canada ($1.93B), Australia ($1.88B), and United States ($1.77B).

Net Trade (2022)

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with